相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Escitalopram in the acute treatment of depressed patients aged 60 years or older
Anjana Bose et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Treatment of vascular depression using repetitive transcranial magnetic stimulation
Ricardo E. Jorge et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Selective publication of antidepressant trials and its influence on apparent efficacy
Erick H. Turner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression. A double-blind, randomised, sham-controlled trial
L. G. Bretlau et al.
PHARMACOPSYCHIATRY (2008)
Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and drug administration
Irving Kirsch et al.
PLOS MEDICINE (2008)
A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression
A. Mogg et al.
PSYCHOLOGICAL MEDICINE (2008)
Antidepressant effects of augmentative transcranial magnetic stimulation -: Randomised multicentre trial
U. Herwig et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: A meta-analysis
George I. Papakostas et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Adjunctive fast repetitive transcranial magnetic stimulation in depression
Ian M. Anderson et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Long-lasting effects of high frequency repetitive transcranial magnetic stimulation in major depressed patients
Marco Bortolomasi et al.
PSYCHIATRY RESEARCH (2007)
Sham-controlled trial of the efficacy and safety of twice-daily rTMS in major depression
Colleen K. Loo et al.
PSYCHOLOGICAL MEDICINE (2007)
Reporting methods of blinding in randomized trials assessing nonpharmacological treatments
Isabelle Boutron et al.
PLOS MEDICINE (2007)
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study
Andrew A. Nierenberg et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials - Meta-analysis
Michael A. Posternak et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Patients with a major depressive episode responding to treatment with repetitive transcranial magnetic stimulation (rTMS) are resistant to the effects of rapid tryptophan depletion
John P. O'Reardon et al.
DEPRESSION AND ANXIETY (2007)
Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies
M. Gross et al.
ACTA PSYCHIATRICA SCANDINAVICA (2007)
Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: A review
Lucie L. Hermann et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation
Felipe Fregni et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram
Dan J. Stein et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Bupropion extended release compared with escitalopram: Effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies
Anita H. Clayton et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression
KD Wagner et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2006)
Sham device versus inert pill: randomised controlled trial of two placebo treatments
TJ Kaptchuk et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
High (20-Hz) and low (1-Hz) frequency transcranial magnetic stimulation as adjuvant treatment in medication-resistant depression
M Garcia-Toro et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2006)
A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression
DH Avery et al.
BIOLOGICAL PSYCHIATRY (2006)
A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression
PB Fitzgerald et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
A double-blind sham controlled study of right prefrontal repetitive transcranial magnetic stimulation (rTMS): Therapeutic and cognitive effect in medication free unipolar depression during 4 weeks
D Januel et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial
D Rossini et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature
F Fregni et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Transcranial magnetic stimulation in treatment-resistant depressed patients: A double-blind, placebo-controlled trial
D Rossini et al.
PSYCHIATRY RESEARCH (2005)
Control group bias in randomized atypical antipsychotic medication trials for schizophrenia
SW Woods et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Add-on rTMS for medication-resistant depression: A randomized, double-blind, sham-controlled trial in Chinese patients
TP Su et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: A double-blind placebo-controlled study
DO Rumi et al.
BIOLOGICAL PSYCHIATRY (2005)
Repetitive transcranial magnetic stimulation:: a putative add-on treatment for major depression in elderly patients
UP Mosimann et al.
PSYCHIATRY RESEARCH (2004)
Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials
D Fergusson et al.
BRITISH MEDICAL JOURNAL (2004)
Repetitive transcranial magnetic stimulation as treatment of poststroke depression: A preliminary study
RE Jorge et al.
BIOLOGICAL PSYCHIATRY (2004)
Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment
E Poulet et al.
EUROPEAN PSYCHIATRY (2004)
Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation
PE Holtzheimer et al.
DEPRESSION AND ANXIETY (2004)
A 3-month, follow-up, randomized, placebo-controlled study of repetitive transcranial magnetic stimulation in depression
F Koerselman et al.
JOURNAL OF CLINICAL PSYCHIATRY (2004)
Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care
UM Lepola et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2003)
Add-on rTMS for treatment of depression:: a pilot study using stereotaxic coil-navigation according to PET data
U Herwig et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2003)
Repetitive transcranial magnetic stimulation for the treatment of depression -: Systematic review and meta-analysis
JLR Martin et al.
BRITISH JOURNAL OF PSYCHIATRY (2003)
Acceleration and augmentation strategies for treating bipolar depression
LL Altshuler et al.
BIOLOGICAL PSYCHIATRY (2003)
Does prophylaxis-delay in bipolar disorder influence outcome?: Results from a long-term study of 147 patients
C Baethge et al.
ACTA PSYCHIATRICA SCANDINAVICA (2003)
Meta-analysis of placebo rates in major depressive disorder trials
P Stolk et al.
ANNALS OF PHARMACOTHERAPY (2003)
Lack of a therapeutic effect of a 2-week sub-threshold transcranial magnetic stimulation course for treatment-resistant depression
NN Boutros et al.
PSYCHIATRY RESEARCH (2002)
Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care
A Wade et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2002)
What are the main methodological problems in the estimation of placebo effects?
A Hróbjartsson
JOURNAL OF CLINICAL EPIDEMIOLOGY (2002)
Placebo response in studies of major depression - Variable, substantial, and growing
BT Walsh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients
WJ Burke et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Patients' perceptions of route of nonsteroidal anti-inflammatory drug administration and its effect on analgesia
NA Schwartz et al.
ACADEMIC EMERGENCY MEDICINE (2000)
Do medical devices have enhanced placebo effects?
TJ Kaptchuk et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)
Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos
AJM de Craen et al.
JOURNAL OF NEUROLOGY (2000)
Transcranial magnetic stimulation (TMS) in controlled treatment studies: Are some sham forms active?
CK Loo et al.
BIOLOGICAL PSYCHIATRY (2000)
分享论文
